Pediatrics Doctors in Germantown, MD Accepting Medicare

27 Pediatrics doctors found. Showing 21 - 27

Albert C Hsu, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19735 Germantown Rd, Suite 200, Germantown, MD 20874 Phone: 301-540-0811

Matthew H Fishel, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19735 Germantown Rd, Suite 200, Germantown, MD 20874 Phone: 301-540-0811

Cynthia Lauta, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19522 Doctors Dr, Germantown, MD 20874 Phone: 301-540-5900

Dr. Nestor A Alvarado, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 20904 Seneca Meadows Pkwy, Germantown, MD 20876 Phone: 240-686-3160    Fax: 240-686-3110

Sandra A Takai, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 19735 Germantown Rd, Suite 200, Germantown, MD 20874 Phone: 301-540-0811    Fax: 301-540-0865

Joann Hyeyun Kang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 20400 Observation Dr, Suite 205, Germantown, MD 20876 Phone: 301-972-9559    Fax: 301-972-9593

Wendy Rumble Vanbronkhorst, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 19803 Executive Park Cir, Germantown, MD 20874 Phone: 301-540-7496    Fax: 301-540-0772

News Archive

EMAS publishes clinical guide on lichen sclerosus in Maturitas journal

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in its journal Maturitas on lichen sclerosus with summary recommendations.

Tips for participant fundraiser to raise dollars for charity

Many of these events are designed to help raise much needed funds for nonprofits while creating a sense of community and providing an outlet for physical activity. While most participants have a plan for improving their health and fitness, when it comes to raising funds for the nonprofit they don't know where to start, feel uncomfortable or are hesitant to ask people for money.

Acorda Therapeutics announces Phase 3 Fampridine-SR trial findings

Data from a long-term open-label extension study from the first Phase 3 Fampridine-SR trial, known as MS-F203, showed that 24.9% of extension study participants with multiple sclerosis (MS) met the criteria as Extension Timed Walk Responders (ETWRs) after one year of treatment and demonstrated improved walking speed over a two year period.

Aetna commends FDA's decision on hydroxyprogesterone caproate

The United States Food and Drug Administration today announced that specialty pharmacies can continue compounding 17P based on a valid prescription for an individually identified patient.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)